FDA-approved

Latisse

LATISSE Your Lashes

LATISSE® is the first and only FDA-approved prescription for the treatment of inadequate or not enough eyelashes. LATISSE® is used to grow eyelashes, making them longer, thicker and darker.

Perhaps you’ve noticed a change in your lashes over the years. Have they lost their fullness? Do they appear shorter? Or lighter in color? If so, it’s time to consider LATISSE® — the first and only FDA-approved product that grows lashes, increasing their overall prominence. Then, ask your doctor if it’s right for you.

HOW DOES

LATISSE® Works?

LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It is not an illusion of growth. It is real lash growth.

HOW DO

I Use Latisse®?

This treatment is to be performed in the evening, after your face is clean, and makeup and contact lenses are removed. Once nightly, place one drop of Latisse® on the disposable sterile applicator supplied with the package, and apply evenly along the skin of upper eyelid margin, at the base of the eyelashes. The upper lid margin in the area of the lash growth should feel slightly moist without runoff. *Blot any excess solution, runoff, outside the upper eyelid area with a tissue or other absorbent cloth.

Dispose of applicator after one use. Repeat for the opposite eyelid, using a new sterile applicator. Do Not reuse applicators and Do Not use any other brush or applicator to apply Latisse®.

Schedule an appointment today, for your complimentary consultation to learn if Latisse® is right for you.

*ADDITIONAL APPLICATIONS OF LATISSE® WILL NOT INCREASE GROWTH OF EYELASHES.
*UPON DISCONTINUATION OF TREATMENT EYELASH GROWTH IS EXPECTED TO RETURN TO ITS PRE-TREATMENT LEVEL.
FOR MORE INFORMATION PLEASE VISIT WWW.LATISSE.COM